222 related articles for article (PubMed ID: 9723886)
1. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
Ram PT; Kiefer T; Silverman M; Song Y; Brown GM; Hill SM
Mol Cell Endocrinol; 1998 Jun; 141(1-2):53-64. PubMed ID: 9723886
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth factors on estrogen receptor mediated gene expression.
Hafner F; Holler E; von Angerer E
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422
[TBL] [Abstract][Full Text] [Related]
4. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin.
Ram PT; Yuan L; Dai J; Kiefer T; Klotz DM; Spriggs LL; Hill SM
J Pineal Res; 2000 May; 28(4):210-8. PubMed ID: 10831156
[TBL] [Abstract][Full Text] [Related]
5. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
6. EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway.
Gehm BD; McAndrews JM; Jordan VC; Jameson JL
Mol Cell Endocrinol; 2000 Jan; 159(1-2):53-62. PubMed ID: 10687852
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells.
Kiefer T; Ram PT; Yuan L; Hill SM
Breast Cancer Res Treat; 2002 Jan; 71(1):37-45. PubMed ID: 11859872
[TBL] [Abstract][Full Text] [Related]
9. Ligand-independent activation of steroid receptors.
Flint AP; Sheldrick EL; Fisher PA
Domest Anim Endocrinol; 2002 Jul; 23(1-2):13-24. PubMed ID: 12142222
[TBL] [Abstract][Full Text] [Related]
10. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Lazennec G; Katzenellenbogen BS
Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of cathepsin D gene expression by growth factors.
Wang F; Duan R; Chirgwin J; Safe SH
J Mol Endocrinol; 2000 Apr; 24(2):193-202. PubMed ID: 10750020
[TBL] [Abstract][Full Text] [Related]
12. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer.
Molis TM; Spriggs LL; Jupiter Y; Hill SM
J Pineal Res; 1995 Mar; 18(2):93-103. PubMed ID: 7629697
[TBL] [Abstract][Full Text] [Related]
13. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
14. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
15. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Sampath D; Winneker RC; Zhang Z
Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
[TBL] [Abstract][Full Text] [Related]
16. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
[TBL] [Abstract][Full Text] [Related]
17. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.
Kato S; Endoh H; Masuhiro Y; Kitamoto T; Uchiyama S; Sasaki H; Masushige S; Gotoh Y; Nishida E; Kawashima H; Metzger D; Chambon P
Science; 1995 Dec; 270(5241):1491-4. PubMed ID: 7491495
[TBL] [Abstract][Full Text] [Related]
18. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Lee AV; Weng CN; Jackson JG; Yee D
J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
[TBL] [Abstract][Full Text] [Related]
19. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
20. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
